Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angong Niuhuang Boluses for acute ischemic stroke with phlegm-heat syndrome
ChiCTR-TRC-10001016Phase 4Completed
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Angong Niuhuang Pill in ischemic stroke (2 arms), sponsored by Beijing University of Chinese Medicine. Primary endpoints: Modified Rankin Scale score at day 90 after stroke onset, Ischemic Stroke TCM Syndrome Factor Diagnostic Scale at day 14 after stroke onset and 1 more. Started Oct 2010; status: completed.
02
Drugs
Angong Niuhuang Pill
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-TRC-10001016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001016.